{"id":3661,"date":"2017-08-12T19:17:47","date_gmt":"2017-08-12T19:17:47","guid":{"rendered":"https:\/\/andromedichyperthermia.com\/non-invasive-treatment\/"},"modified":"2026-02-11T09:09:16","modified_gmt":"2026-02-11T09:09:16","slug":"mitteinvasiivne-vahiravi-hupertermia","status":"publish","type":"page","link":"https:\/\/andromedichyperthermia.com\/et\/mitteinvasiivne-vahiravi-hupertermia\/","title":{"rendered":"Mitteinvasiivne ravi, s\u00fcnergiline keemia-, raadio- ja immuunteraapiaga"},"content":{"rendered":"<p><script type=\"application\/ld+json\">\n{\n  \"@context\": \"https:\/\/schema.org\",\n  \"@graph\": [\n    {\n      \"@type\": [\"Product\", \"MedicalDevice\"],\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/et\/sugav-lokaalne-hupertermia-seade\/#product\",\n      \"name\": \"Andromedic HyDeep 600WM\",\n      \"description\": \"HyDeep 600 WM on s\u00fcsteem\/seade t\u00e4iustatud onkoloogiliseks h\u00fcpertermiaks, s\u00fcgav lokaalne h\u00fcpertermia s\u00fcsteem\/seade ja moduleeritud raadiosagedusliku (RF) h\u00fcpertermia s\u00fcste\/seade, elektro-h\u00fcpertermia s\u00fcsteem\/seade. Professionaalne onkoloogiline RF-h\u00fcpertermia seade moduleeritud 13,56 MHz teraapiaks.\",\n      \"brand\": { \n        \"@type\": \"Brand\",\n        \"@id\": \"https:\/\/andromedichyperthermia.com\/#brand\",\n        \"name\": \"Andromedic\" \n      },\n      \"manufacturer\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/#organization\" },\n      \"aggregateRating\": {\n        \"@type\": \"AggregateRating\",\n        \"ratingValue\": \"4.9\",\n        \"reviewCount\": \"40\",\n        \"bestRating\": \"5\",\n        \"worstRating\": \"4\"\n      }\n    },\n    {\n      \"@type\": \"MedicalWebPage\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/et\/mitteinvasiivne-vahiravi-hupertermia\/#webpage\",\n      \"url\": \"https:\/\/andromedichyperthermia.com\/et\/mitteinvasiivne-vahiravi-hupertermia\/\",\n      \"name\": \"13,56 MHz moduleeritud RF-h\u00fcpertermia (mHT) \u2013 mitteinvasiivne v\u00e4hiravi\",\n      \"description\": \"P\u00f5hjalik juhend moduleeritud RF-h\u00fcpertermia (mHT) kohta seadmega HyDeep 600WM. Uurige mitteinvasiivse onkoloogilise teraapia eeliseid.\",\n      \"isPartOf\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/#website\" },\n      \"inLanguage\": \"et\",\n      \"lastReviewed\": \"2026-02-11\",\n      \"reviewedBy\": { \n        \"@type\": \"Person\",\n        \"@id\": \"https:\/\/andromedichyperthermia.com\/hyperthermia-doctor-salvatore-conte\/\" \n      },\n      \"mainEntity\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/et\/mitteinvasiivne-vahiravi-hupertermia\/#therapy\" },\n      \"about\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/et\/sugav-lokaalne-hupertermia-seade\/#product\" }\n    },\n    {\n      \"@type\": \"MedicalTherapy\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/et\/mitteinvasiivne-vahiravi-hupertermia\/#therapy\",\n      \"name\": \"Moduleeritud RF-h\u00fcpertermia (mHT)\",\n      \"description\": \"Mitteinvasiivne v\u00e4hiteraapia, mida teostatakse seadmega HyDeep 600WM, kasutades t\u00e4iustatud raadiosagedust v\u00e4hirakkude selektiivseks h\u00e4vitamiseks.\",\n      \"relevantSpecialty\": { \"@type\": \"MedicalSpecialty\", \"name\": \"Oncology\" },\n      \"device\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/et\/sugav-lokaalne-hupertermia-seade\/#product\" }\n    },\n    {\n      \"@type\": \"BreadcrumbList\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/et\/mitteinvasiivne-vahiravi-hupertermia\/#breadcrumb\",\n      \"itemListElement\": [\n        {\n          \"@type\": \"ListItem\",\n          \"position\": 1,\n          \"item\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/et\/\", \"name\": \"Avaleht\" }\n        },\n        {\n          \"@type\": \"ListItem\",\n          \"position\": 2,\n          \"item\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/et\/mitteinvasiivne-vahiravi-hupertermia\/\", \"name\": \"Mitteinvasiivne ravi\" }\n        }\n      ]\n    },\n    {\n      \"@type\": \"MedicalOrganization\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/#organization\",\n      \"name\": \"Andromedic Hyperthermia\",\n      \"url\": \"https:\/\/andromedichyperthermia.com\/et\/\",\n      \"logo\": {\n        \"@type\": \"ImageObject\",\n        \"url\": \"https:\/\/andromedichyperthermia.com\/logo.png\"\n      }\n    }\n  ]\n}\n<\/script><\/p>\n<div class=\"andromedic-content-section\" style=\"font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;\">\n<div style=\"text-align: center; padding: 50px 20px; background: linear-gradient(180deg, #f0f7ff 0%, #ffffff 100%); border-radius: 0 0 30px 30px; margin-bottom: 40px;\">\n<h1 style=\"color: #004a99; font-size: 2.3em; line-height: 1.2; margin-bottom: 20px;\">Mitteinvasiivne v\u00e4hiravi:<br \/>\n<span style=\"color: #003366; font-weight: 400;\">13,56 MHz moduleeritud RF-h\u00fcpertermia (mHT)<\/span><\/h1>\n<p style=\"font-size: 1.15em; line-height: 1.8; color: #444; max-width: 950px; margin: 0 auto;\">Raadiosageduslik (RF) h\u00fcpertermia on innovaatiline ja <strong>t\u00e4ielikult mitteinvasiivne<\/strong> onkoloogiline sekkumine. Kasutades 13,56 MHz elektromagnetlaineid pahaloomuliste rakkude selektiivseks sihtimiseks, muudab see kasvajad standardravile vastuv\u00f5tlikumaks ilma f\u00fc\u00fcsilise traumata. <span style=\"color: #004a99; font-weight: 600;\">Mitteinvasiivsus on oluline kliiniline eelis<\/span>: protseduur ei vaja kirurgilisi sissel\u00f5ikeid, n\u00f5elu ega punktsioone.<\/p>\n<\/div>\n<div style=\"display: flex; flex-wrap: wrap; gap: 40px; align-items: flex-start; margin-bottom: 60px; padding: 0 20px;\">\n<div style=\"flex: 1.2; min-width: 350px;\">\n<figure style=\"margin: 0; box-shadow: 0 15px 35px rgba(0,0,0,0.1); border-radius: 15px; overflow: hidden;\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-517\" style=\"width: 100%; display: block;\" src=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Video-HYDEEP-HQ-SalvatoreSettaggi_Moment-1024x576-1.webp\" alt=\"HyDeep 600WM moduleeritud RF-h\u00fcpertermia seade - mitteinvasiivne v\u00e4hiteraapia -Mitteinvasiivne v\u00e4hiravi\" width=\"1024\" height=\"576\" title=\"\" srcset=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Video-HYDEEP-HQ-SalvatoreSettaggi_Moment-1024x576-1.webp 1024w, https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Video-HYDEEP-HQ-SalvatoreSettaggi_Moment-1024x576-1-300x169.webp 300w, https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Video-HYDEEP-HQ-SalvatoreSettaggi_Moment-1024x576-1-768x432.webp 768w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><figcaption style=\"padding: 20px; background: #f9f9f9; font-size: 0.95em; color: #555; border-top: 1px solid #eee; line-height: 1.6;\"><strong>Andromedic HyDeep 600WM<\/strong>, t\u00e4iustatud onkoloogilise h\u00fcpertermia seade, illustreerib t\u00e4iuslikult mHT mitteinvasiivset olemust, pakkudes patsiendile maksimaalset mugavust ilma kehasse sisestatavate kirurgiliste instrumentideta.<\/figcaption><\/figure>\n<p style=\"margin-top: 25px; font-size: 1.1em; line-height: 1.7; color: #333; padding-left: 20px; border-left: 4px solid #004a99;\">Teaduslikud kliinilised uuringud kinnitavad, et mHT integreerimine onkoloogilistesse protokollidesse parandab <strong>\u00fcldist elulemust (OS)<\/strong>, lokaalset kasvaja kontrolli (LTC) ja patsiendi elukvaliteeti. <a style=\"color: #004a99; text-decoration: none; font-weight: bold;\" title=\"Vaata teaduslikku viidet moduleeritud elektro-h\u00fcpertermia kohta\" href=\"https:\/\/www.mdpi.com\/2072-6694\/15\/18\/4569\" target=\"_blank\" rel=\"noopener\">(Teaduslik viide)<\/a><\/p>\n<\/div>\n<div style=\"flex: 0.8; min-width: 300px; background: #f4f7fa; padding: 30px; border-radius: 20px;\">\n<nav aria-label=\"Quick Navigation\">\n<h4 style=\"margin-top: 0; color: #003366; border-bottom: 2px solid #004a99; padding-bottom: 10px; text-transform: uppercase; font-size: 0.9em; letter-spacing: 1px;\">Teaduslik navigatsioon:<\/h4>\n<ul style=\"list-style: none; padding: 0; margin: 20px 0 0 0;\">\n<li style=\"margin-bottom: 12px;\"><a style=\"text-decoration: none; color: #004a99; font-weight: 500;\" href=\"#section1\">Toimemehhanism<\/a><\/li>\n<li style=\"margin-bottom: 12px;\"><a style=\"text-decoration: none; color: #004a99; font-weight: 500;\" href=\"#section2\">S\u00fcnergia keemiaraviga<\/a><\/li>\n<li style=\"margin-bottom: 12px;\"><a style=\"text-decoration: none; color: #004a99; font-weight: 500;\" href=\"#section3\">Immunoteraapia aktiveerimine<\/a><\/li>\n<li style=\"margin-bottom: 12px;\"><a style=\"text-decoration: none; color: #004a99; font-weight: 500;\" href=\"#section4\">Palliatiivne ja adjuvantne kasutus<\/a><\/li>\n<li><a style=\"text-decoration: none; color: #004a99; font-weight: 500;\" href=\"#section5\">Kliinilised tulemused<\/a><\/li>\n<\/ul>\n<\/nav>\n<\/div>\n<\/div>\n<section id=\"section1\" style=\"margin-bottom: 60px; padding: 40px; background: #fff; border: 1px solid #e1e8f0; border-radius: 20px; text-align: center;\">\n<h2 style=\"color: #004a99; margin-bottom: 20px;\">Moduleeritud RF-i biof\u00fc\u00fcsikalised mehhanismid ja kliinilised eelised<\/h2>\n<p style=\"max-width: 850px; margin: 0 auto; font-size: 1.1em; line-height: 1.8; color: #555;\"><strong>Moduleeritud RF-h\u00fcpertermia<\/strong> mehhanism on mitmetahuline, m\u00f5jutades kasvaja mikrokeskkonda (TME) ja s\u00fcsteemset immuunvastust, s\u00e4ilitades samal ajal rangelt mitteinvasiivse profiili.<\/p>\n<\/section>\n<h2 id=\"section2\" style=\"color: #004a99; text-align: center; margin-bottom: 40px;\">Kliiniline s\u00fcnergia: standardsete onkoloogiliste ravimeetodite t\u00f5hustamine<\/h2>\n<div style=\"display: flex; flex-wrap: wrap; gap: 30px; margin-bottom: 50px; padding: 0 20px;\">\n<div style=\"flex: 1; min-width: 320px; background: #fff; border: 1px solid #e1e8f0; padding: 35px; border-radius: 20px; box-shadow: 0 5px 15px rgba(0,0,0,0.03);\">\n<h3 style=\"color: #004a99; margin-top: 0; font-size: 1.4em;\">1. S\u00fcnergia keemiaraviga (perfusioon)<\/h3>\n<p style=\"line-height: 1.7; color: #444;\">mHT k\u00e4ivitab lokaalse vasodilatatsiooni kasvaja mikrotsirkulatsioonis, h\u00f5lbustades ts\u00fctotoksiliste ainete paremat tungimist kasvajasse.<\/p>\n<div style=\"background: #f0f7ff; padding: 15px; border-radius: 10px; border-left: 4px solid #004a99; margin-top: 15px;\"><strong>Terapeutiline m\u00f5ju:<\/strong> Suurendab keemiaravi efektiivsust <strong>ilma s\u00fcsteemset toksilisust t\u00f5stmata<\/strong>.<\/div>\n<\/div>\n<div style=\"flex: 1; min-width: 320px; background: #fff; border: 1px solid #e1e8f0; padding: 35px; border-radius: 20px; box-shadow: 0 5px 15px rgba(0,0,0,0.03);\">\n<h3 style=\"color: #cc0000; margin-top: 0; font-size: 1.4em;\">2. Radiosenzitiseerimine (reoksigenatsioon)<\/h3>\n<p style=\"line-height: 1.7; color: #444;\">Parandades kasvajasiseset hapnikuga varustatust, elimineerib mHT kiiritusresistentsed h\u00fcpoksilised osad, muutes v\u00e4hirakud kiiritusravile oluliselt vastuv\u00f5tlikumaks.<\/p>\n<div style=\"background: #fff5f5; padding: 15px; border-radius: 10px; border-left: 4px solid #cc0000; margin-top: 15px;\"><strong>Radiosenzitiseeriv toime:<\/strong> Tugevdab kiiritusravi vastust <strong>patsiendis\u00f5braliku ja mitteagressiivse protokolli<\/strong> kaudu.<\/div>\n<\/div>\n<\/div>\n<section id=\"section3\" style=\"margin-bottom: 60px; padding: 45px; background: #f8fbff; border-radius: 25px; border: 1px solid #d0e1f5;\">\n<div style=\"text-align: center; margin-bottom: 40px;\">\n<div style=\"display: inline-block; background: #004a99; color: #fff; padding: 5px 15px; border-radius: 50px; font-size: 0.85em; font-weight: bold; margin-bottom: 15px; text-transform: uppercase; letter-spacing: 1px;\">T\u00e4iustatud immuunonkoloogia<\/div>\n<h2 style=\"color: #003366; margin-top: 0;\">Immuuns\u00fcsteemi aktiveerimine moduleeritud RF-i kaudu<\/h2>\n<p style=\"max-width: 800px; margin: 0 auto; font-size: 1.1em; line-height: 1.7; color: #444;\">Moduleeritud RF-h\u00fcpertermia toimib bioloogiliste signaaliradade kaudu kasvavajavastase immuunvastuse katal\u00fcsaatorina.<\/p>\n<\/div>\n<div style=\"display: flex; flex-direction: column; gap: 25px;\">\n<div style=\"background: #ffffff; border: 1px solid #e1e8f0; padding: 30px; border-radius: 15px; box-shadow: 0 4px 12px rgba(0,0,0,0.03);\">\n<h4 style=\"color: #004a99; margin: 0 0 10px 0; font-size: 1.25em;\">Immunogeenne rakusurm (ICD) ja DAMP-id<\/h4>\n<p style=\"line-height: 1.7; color: #333;\">mHT indutseerib <strong>immunogeenset rakusurma (ICD)<\/strong>, vallandades ohusignaalide (<em>Damage-Associated Molecular Patterns &#8211; DAMPs<\/em>) vabanemise. Need signaalid hoiatavad immuuns\u00fcsteemi ja soodustavad pikaajalist immunoloogilist m\u00e4lu mitteinvasiivse stiimuli abil.<\/p>\n<\/div>\n<div style=\"background: #ffffff; border: 1px solid #e1e8f0; padding: 30px; border-radius: 15px; box-shadow: 0 4px 12px rgba(0,0,0,0.03);\">\n<h4 style=\"color: #004a99; margin: 0 0 10px 0; font-size: 1.25em;\">S\u00fcsteemsed m\u00f5jud: Abscopal-efekt<\/h4>\n<p style=\"line-height: 1.7; color: #333;\">Lokaalne mHT-ravi v\u00f5ib esile kutsuda s\u00fcsteemse kasvajavastase vastuse kaugetes metastaasides, toimides mitteinvasiivse partnerina immuunkontrollpunkti inhibiitoritele.<\/p>\n<\/div>\n<\/div>\n<\/section>\n<section id=\"section4\" style=\"margin-bottom: 60px; padding: 0 20px;\">\n<h2 style=\"color: #004a99; text-align: center; margin-bottom: 40px;\">Kliinilised rakendused: leebe valik igas etapis<\/h2>\n<div style=\"display: grid; grid-template-columns: repeat(auto-fit, minmax(300px, 1fr)); gap: 25px;\">\n<div style=\"background: #ffffff; border: 1px solid #e1e8f0; padding: 25px; border-radius: 15px; border-top: 4px solid #004a99;\">\n<h3 style=\"color: #004a99; margin-top: 0; font-size: 1.2em;\">Adjuvantne ja neoadjuvantne tugi<\/h3>\n<p style=\"font-size: 0.95em; line-height: 1.6; color: #444;\">Suurendab esmaste ravimeetodite edukust <strong>ilma t\u00e4iendava invasiivse koormuseta<\/strong> kliinilisele protokollile.<\/p>\n<\/div>\n<div style=\"background: #ffffff; border: 1px solid #e1e8f0; padding: 25px; border-radius: 15px; border-top: 4px solid #004a99;\">\n<h3 style=\"color: #004a99; margin-top: 0; font-size: 1.2em;\">Palliatiivne ravi ja valu juhtimine<\/h3>\n<p style=\"font-size: 0.95em; line-height: 1.6; color: #444;\">V\u00e4hendab oluliselt v\u00e4hist tingitud valu. Selle leebe iseloom parandab elukvaliteeti (QoL) kaugelearenenud onkoloogiliste seisundite puhul.<\/p>\n<\/div>\n<div style=\"background: #ffffff; border: 1px solid #e1e8f0; padding: 25px; border-radius: 15px; border-top: 4px solid #004a99;\">\n<h3 style=\"color: #004a99; margin-top: 0; font-size: 1.2em;\">P\u00f5letikulised patoloogiad<\/h3>\n<p style=\"font-size: 0.95em; line-height: 1.6; color: #444;\">V\u00f5imaldab ravida kroonilist p\u00f5letikku ja kaasnevaid patoloogiaid sama <strong>ohutu ja mitteinvasiivse tehnoloogia<\/strong> abil.<\/p>\n<\/div>\n<\/div>\n<\/section>\n<section id=\"section5\" style=\"background: linear-gradient(135deg, #004a99 0%, #002b5c 100%); color: #ffffff; padding: 50px; border-radius: 30px; position: relative; overflow: hidden; margin-bottom: 50px;\">\n<div style=\"position: relative; z-index: 2; text-align: center;\">\n<h2 style=\"color: #ffffff; margin-top: 0; margin-bottom: 25px;\">Kliinilised t\u00f5endid ja tulevikuvaated<\/h2>\n<div style=\"display: flex; flex-wrap: wrap; gap: 30px; justify-content: center; margin-bottom: 40px;\">\n<div style=\"background: rgba(255,255,255,0.1); padding: 20px 40px; border-radius: 15px; border: 1px solid rgba(255,255,255,0.2);\"><span style=\"display: block; font-size: 2em; font-weight: bold;\">Pikenenud<\/span><a href=\"https:\/\/andromedichyperthermia.com\/et\/hupertermia-vahiga-patsientide-elulemus\/\"><span style=\"font-size: 1.1em; opacity: 0.9; color: #fff; text-decoration: underline;\">\u00dcldine elulemus (OS)<\/span><\/a><\/div>\n<div style=\"background: rgba(255,255,255,0.1); padding: 20px 40px; border-radius: 15px; border: 1px solid rgba(255,255,255,0.2);\"><span style=\"display: block; font-size: 2em; font-weight: bold;\">&#x2728; Paranenud<\/span><a href=\"https:\/\/andromedichyperthermia.com\/et\/hupertermia-moju-elukvaliteedile-qol\/\"><span style=\"font-size: 1.1em; opacity: 0.9; color: #fff; text-decoration: underline;\">Elukvaliteet (QoL)<\/span><\/a><\/div>\n<\/div>\n<p style=\"font-size: 1.15em; line-height: 1.8; max-width: 850px; margin: 0 auto;\">Moduleeritud RF-h\u00fcpertermia (mHT) on oluline t\u00f5endusp\u00f5hine teraapia, mis maksimeerib ravi efektiivsust l\u00e4bi <strong>mitteinvasiivse meetodi<\/strong>, austades patsiendi heaolu.<\/p>\n<\/div>\n<div style=\"position: absolute; right: -50px; bottom: -50px; font-size: 15em; opacity: 0.05; color: #fff; font-weight: 900;\">mHT<\/div>\n<\/section>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Moduleeritud RF-h\u00fcpertermia (mHT) on mitteinvasiivne sekkumine, mis kasutab elektromagnetlaineid pahaloomuliste kudede selektiivseks sihtimiseks, s\u00e4\u00e4stes samal ajal terveid rakke. V\u00f5imsa multimodaalse s\u00fcnergistina tugevdab mHT keemia- ja kiiritusravi, immunoteraapiat ning immuunkontrollpunkti inhibiitorite toimet.<\/p>\n<p>Kasutades HyDeep 600WM s\u00fcsteemi (t\u00e4iustatud onkoloogilise h\u00fcpertermia seade \/ s\u00fcva-lokaalse h\u00fcpertermia seade), saavutatakse m\u00e4rkimisv\u00e4\u00e4rne radiosenzitiseerimine (reoksigenatsioon) ja \u00fclim kemoterapeutiline perfusioon. Lisaks soojuslikule toimele moduleerib see kasvaja mikrokeskkonda (TME), k\u00e4ivitades immunogeense rakusurma (ICD) ja ohusignaalide (DAMPs) vabanemise. Need mehhanismid tagavad pikema \u00fcldise elulemuse (OS), parema lokaalse kasvaja kontrolli ja k\u00f5rgema elukvaliteedi. See on ideaalne adjuvantne v\u00f5i palliatiivne lahendus onkoloogiliste patoloogiate, kroonilise p\u00f5letiku ja valu juhtimise korral.<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-3661","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/andromedichyperthermia.com\/et\/wp-json\/wp\/v2\/pages\/3661","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/andromedichyperthermia.com\/et\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/andromedichyperthermia.com\/et\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/et\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/et\/wp-json\/wp\/v2\/comments?post=3661"}],"version-history":[{"count":0,"href":"https:\/\/andromedichyperthermia.com\/et\/wp-json\/wp\/v2\/pages\/3661\/revisions"}],"wp:attachment":[{"href":"https:\/\/andromedichyperthermia.com\/et\/wp-json\/wp\/v2\/media?parent=3661"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}